ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BMTX1Y45
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerI500.AS(USD) CXE
ETF TickerI500.DE(EUR) CXE
ETF TickerI500.LS(GBP) CXE
ETF TickerI500(EUR) ETF Plus

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares S&P 500 Swap UCITS ETF USD (Acc) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-11-20 (Thursday)-16,689ALNY holding increased by 33378USD -7,439,789ALNY holding increased by 15129413USD -7,439,78933,378USD 15,129,413 USD 445.79 USD 0
2025-11-20 (Thursday)16,689ALNY holding increased by 33378USD 7,439,789ALNY holding increased by 15129413USD 7,439,78933,378USD 15,129,413 USD 445.79 USD 0
2025-11-19 (Wednesday)-16,689ALNY holding increased by 33378USD -7,689,624ALNY holding increased by 15404949USD -7,689,62433,378USD 15,404,949 USD 460.76 USD 0
2025-11-19 (Wednesday)16,689ALNY holding increased by 33378USD 7,689,624ALNY holding increased by 15404949USD 7,689,62433,378USD 15,404,949 USD 460.76 USD 0
2025-11-18 (Tuesday)-16,689ALNY holding increased by 33378USD -7,715,325ALNY holding increased by 15401277USD -7,715,32533,378USD 15,401,277 USD 462.3 USD 0
2025-11-18 (Tuesday)16,689ALNY holding increased by 33378USD 7,715,325ALNY holding increased by 15401277USD 7,715,32533,378USD 15,401,277 USD 462.3 USD 0
2025-11-17 (Monday)-16,689ALNY holding increased by 33378USD -7,685,952ALNY holding increased by 15181983USD -7,685,95233,378USD 15,181,983 USD 460.54 USD 0
2025-11-17 (Monday)16,689ALNY holding increased by 33378USD 7,685,952ALNY holding increased by 15181983USD 7,685,95233,378USD 15,181,983 USD 460.54 USD 0
2025-11-14 (Friday)-16,689ALNY holding increased by 33378USD -7,496,031ALNY holding increased by 15072336USD -7,496,03133,378USD 15,072,336 USD 449.16 USD 0
2025-11-14 (Friday)16,689ALNY holding increased by 33378USD 7,496,031ALNY holding increased by 15072336USD 7,496,03133,378USD 15,072,336 USD 449.16 USD 0
2025-11-13 (Thursday)-16,689ALNY holding increased by 33378USD -7,576,305ALNY holding increased by 15132083USD -7,576,30533,378USD 15,132,083 USD 453.97 USD 0
2025-11-13 (Thursday)16,689ALNY holding increased by 33378USD 7,576,305ALNY holding increased by 15132083USD 7,576,30533,378USD 15,132,083 USD 453.97 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00BMTX1Y45

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-20BUY33,378467.730445.340 447.579USD 14,939,292 318.00
2025-11-19BUY33,378465.320456.900 457.742USD 15,278,512 317.43
2025-11-18BUY33,378469.110456.270 457.554USD 15,272,237 316.85
2025-11-17BUY33,378463.750449.000 450.475USD 15,035,955 316.27
2025-11-14BUY33,378461.960448.280 449.648USD 15,008,351 315.74
2025-11-13BUY33,378456.140447.155 448.054USD 14,955,130 315.18
2025-11-12BUY33,378459.270447.130 448.344USD 14,964,826 314.62
2025-11-11BUY33,378455.200441.210 442.609USD 14,773,403 314.06
2025-11-10BUY33,378449.680440.930 441.805USD 14,746,567 313.53
2025-11-07BUY33,378443.587430.835 432.110USD 14,422,976 313.00
2025-11-06BUY33,378445.490429.000 430.649USD 14,374,202 312.47
2025-11-05BUY33,378438.530417.000 419.153USD 13,990,489 311.97
2025-11-04BUY33,378431.500421.830 422.797USD 14,112,118 311.50
2025-11-03BUY33,378457.260429.615 432.379USD 14,431,963 310.99
2025-10-31BUY33,378459.570441.220 443.055USD 14,788,290 310.38
2025-10-30BUY27,656471.980436.512 440.059USD 12,170,264 309.79
2025-10-29BUY21,934481.590482.730 482.616USD 10,585,697 309.07
2025-10-28BUY21,934475.910484.610 483.740USD 10,610,353 308.36
2025-10-27BUY21,934478.580485.360 484.682USD 10,631,015 307.63
2025-10-24BUY21,934463.430469.290 468.704USD 10,280,554 306.96
2025-10-23BUY21,934464.000468.860 468.374USD 10,273,315 306.28
2025-10-22BUY21,934464.900480.530 478.967USD 10,505,662 305.60
2025-10-21BUY21,934474.000490.050 488.445USD 10,713,552 304.86
2025-10-20BUY21,934491.220495.550 495.117USD 10,859,896 304.05
2025-10-17BUY21,934481.670492.620 491.525USD 10,781,109 303.27
2025-10-16BUY21,934481.070488.390 487.658USD 10,696,291 302.49
2025-10-15BUY21,934470.270485.280 483.779USD 10,611,209 301.75
2025-10-14BUY21,934469.360479.690 478.657USD 10,498,863 301.00
2025-10-13SELL-21,934464.950473.650 472.780USD -10,369,956 302.18 Loss of -3,741,926 on sale
2025-10-08BUY21,934450.680464.460 463.082USD 10,157,240 301.51
2025-10-07BUY21,934459.580462.630 462.325USD 10,140,637 300.80
2025-10-06BUY21,934452.000458.690 458.021USD 10,046,233 300.12
2025-10-03BUY21,934456.350465.010 464.144USD 10,180,535 299.41
2025-10-02BUY21,934460.990461.530 461.476USD 10,122,015 298.67
2025-10-01BUY21,934460.650467.420 466.743USD 10,237,541 297.93
2025-09-30BUY21,934456.000459.300 458.970USD 10,067,048 297.20
2025-09-29BUY21,934447.490451.630 451.216USD 9,896,972 296.50
2025-09-26BUY21,934446.400453.050 452.385USD 9,922,612 295.81
2025-09-25BUY21,934449.580459.000 458.058USD 10,047,044 295.09
2025-09-24SELL-21,934458.370462.690 462.258USD -10,139,167 296.31 Loss of -3,639,807 on sale
2025-09-18BUY21,934452.170456.940 456.463USD 10,012,060 295.58
2025-09-17BUY21,934451.730463.880 462.665USD 10,148,094 294.84
2025-09-16BUY21,934461.240467.280 466.676USD 10,236,071 294.05
2025-09-15BUY21,934461.140466.240 465.730USD 10,215,322 293.25
2025-09-12BUY21,934465.890475.690 474.710USD 10,412,289 292.42
2025-09-11BUY21,934468.580474.340 473.764USD 10,391,539 291.57
2025-09-10BUY21,934469.310480.050 478.976USD 10,505,859 290.70
2025-09-09BUY21,934482.130484.210 484.002USD 10,616,100 289.77
2025-09-08SELL-21,934455.030463.000 462.203USD -10,137,961 291.03 Loss of -3,754,488 on sale
2025-09-05BUY21,934452.000455.280 454.952USD 9,978,917 290.24
2025-09-04BUY21,934453.540458.300 457.824USD 10,041,911 289.43
2025-09-02BUY21,934447.000454.500 453.750USD 9,952,553 288.65
2025-08-29BUY21,934446.510453.960 453.215USD 9,940,818 287.86
2025-08-28BUY21,934452.330457.290 456.794USD 10,019,320 287.03
2025-08-27BUY21,934454.180455.450 455.323USD 9,987,055 286.19
2025-08-25BUY22,728443.640458.750 457.239USD 10,392,128 285.39
2025-08-22BUY23,522454.380469.810 468.267USD 11,014,576 284.52
2025-08-21BUY23,522467.550467.710 467.694USD 11,001,098 283.59
2025-08-20BUY23,522458.310466.310 465.510USD 10,949,726 282.68
2025-08-19BUY23,522458.280462.880 462.420USD 10,877,043 281.78
2025-08-18BUY23,522456.870457.920 457.815USD 10,768,725 280.86
2025-08-15BUY23,522448.910449.520 449.459USD 10,572,174 279.98
2025-08-13BUY23,522432.520438.230 437.659USD 10,294,615 279.18
2025-08-12BUY23,522429.930437.000 436.293USD 10,262,484 278.38
2025-08-11BUY23,522435.000445.200 444.180USD 10,448,002 277.55
2025-08-08BUY23,522438.930439.360 439.317USD 10,333,614 276.69
2025-08-07BUY23,522435.100436.770 436.603USD 10,269,776 275.84
2025-08-06BUY23,522428.140428.690 428.635USD 10,082,353 275.01
2025-08-05BUY23,522418.910426.760 425.975USD 10,019,784 274.23
2025-08-04BUY23,522419.560422.640 422.332USD 9,934,094 273.44
2025-08-01BUY23,522401.800401.800 401.800USD 9,451,139 272.73
2025-07-31BUY23,522392.240402.430 401.411USD 9,441,989 272.07
2025-07-30BUY23,522339.800345.980 345.362USD 8,123,605 271.69
2025-07-29BUY23,522330.550331.060 331.009USD 7,785,994 271.36
2025-07-28BUY23,522324.790331.430 330.766USD 7,780,278 271.06
2025-07-25BUY23,522328.810331.500 331.231USD 7,791,216 270.74
2025-07-24BUY23,522328.000332.190 331.771USD 7,803,918 270.41
2025-07-23BUY23,522325.640329.340 328.970USD 7,738,032 270.10
2025-07-22BUY23,522325.280326.300 326.198USD 7,672,829 269.78
2025-07-21SELL-23,522320.520328.700 327.882USD -7,712,441 269.18 Loss of -1,380,709 on sale
2025-07-18BUY23,522320.530325.620 325.111USD 7,647,261 268.88
2025-07-17BUY23,522324.690329.870 329.352USD 7,747,018 268.56
2025-07-16BUY23,522322.810323.410 323.350USD 7,605,839 268.24
2025-07-15BUY23,522311.120316.900 316.322USD 7,440,526 267.99
2025-07-14BUY23,522315.750319.180 318.837USD 7,499,684 267.70
2025-07-11BUY23,522314.940321.120 320.502USD 7,538,848 267.42
2025-07-10BUY23,522322.640324.820 324.602USD 7,635,288 267.09
2025-07-09BUY23,522320.870322.680 322.499USD 7,585,821 266.76
2025-07-08BUY23,522317.500328.990 327.841USD 7,711,476 266.45
2025-07-07BUY25,468324.130328.240 327.829USD 8,349,149 266.10
2025-07-04SELL-27,414 373.300* 265.43 Profit of 7,276,631 on sale
2025-07-03BUY27,414331.910333.700 333.521USD 9,143,145 265.02
2025-07-02BUY27,414329.770330.000 329.977USD 9,045,989 264.62
2025-06-30BUY27,414326.090327.210 327.098USD 8,967,064 264.23
2025-06-27BUY27,414322.830323.200 323.163USD 8,859,191 263.86
2025-06-26BUY27,414318.250325.000 324.325USD 8,891,046 263.51
2025-06-25BUY27,414321.940324.320 324.082USD 8,884,384 263.14
2025-06-24BUY27,414325.000326.030 325.927USD 8,934,963 262.74
2025-06-23BUY27,414313.130314.780 314.615USD 8,624,856 262.41
2025-06-20BUY27,414309.700314.500 314.020USD 8,608,544 262.10
2025-06-19BUY27,414 312.320* 261.77
2025-06-18BUY27,414312.320317.540 317.018USD 8,690,732 261.44
2025-06-17BUY27,414308.710309.060 309.025USD 8,471,611 261.12
2025-06-16BUY27,414308.780309.630 309.545USD 8,485,867 260.80
2025-06-13BUY27,414307.990308.020 308.017USD 8,443,978 260.48
2025-06-12BUY27,414304.670307.480 307.199USD 8,421,554 260.18
2025-06-11BUY27,414298.580303.850 303.323USD 8,315,297 259.92
2025-06-10BUY27,414302.460308.890 308.247USD 8,450,284 259.63
2025-06-09BUY27,414304.000306.170 305.953USD 8,387,396 259.32
2025-06-06BUY27,414300.830310.220 309.281USD 8,478,629 259.03
2025-06-05BUY27,414308.000308.530 308.477USD 8,456,588 258.68
2025-06-04BUY27,414305.310308.930 308.568USD 8,459,083 258.35
2025-06-03BUY27,414303.770307.850 307.442USD 8,428,215 258.03
2025-06-02BUY27,414306.090307.190 307.080USD 8,418,291 257.68
2025-05-30BUY27,414304.560306.000 305.856USD 8,384,736 257.34
2025-05-29BUY27,414292.900293.220 293.188USD 8,037,456 257.08
2025-05-28BUY27,414285.560291.540 290.942USD 7,975,884 256.87
2025-05-27BUY27,414290.100295.440 294.906USD 8,084,553 256.63
2025-05-26BUY27,414 289.960* 256.38
2025-05-23BUY27,414289.960291.220 291.094USD 7,980,051 256.13
2025-05-22BUY27,414289.000291.540 291.286USD 7,985,315 255.88
2025-05-21BUY27,414292.580298.230 297.665USD 8,160,189 255.60
2025-05-20BUY27,414291.680292.990 292.859USD 8,028,436 255.32
2025-05-19BUY27,414291.860296.800 296.306USD 8,122,932 255.04
2025-05-16BUY27,414285.310289.750 289.306USD 7,931,035 254.80
2025-05-15BUY27,414283.400285.000 284.840USD 7,808,604 254.58
2025-05-14BUY27,414267.550270.000 269.755USD 7,395,064 254.47
2025-05-13BUY27,414266.860268.070 267.949USD 7,345,554 254.37
2025-05-12BUY27,414270.190270.200 270.199USD 7,407,236 254.25
2025-05-09BUY27,414251.150260.000 259.115USD 7,103,379 254.27
2025-05-08BUY27,414258.350270.000 268.835USD 7,369,843 254.24
2025-05-07BUY27,414276.550277.850 277.720USD 7,613,416 254.05
2025-05-06BUY27,414269.810276.470 275.804USD 7,560,891 253.92
2025-05-05BUY27,414273.550273.970 273.928USD 7,509,462 253.76
2025-05-02BUY27,414259.390265.000 264.439USD 7,249,331 253.71
2025-05-01BUY27,414255.130265.910 264.832USD 7,260,105 253.70
2025-04-30BUY27,414263.240263.680 263.636USD 7,227,317 253.62
2025-04-29BUY27,414257.190260.540 260.205USD 7,133,260 253.58
2025-04-28BUY27,414254.850256.570 256.398USD 7,028,895 253.57
2025-04-25BUY27,414251.560253.250 253.081USD 6,937,963 253.59
2025-04-24BUY27,414242.610243.690 243.582USD 6,677,557 253.69
2025-04-23BUY27,414241.970248.590 247.928USD 6,796,698 253.79
2025-04-22BUY27,414236.750238.630 238.442USD 6,536,649 253.95
2025-04-21BUY27,414232.750237.770 237.268USD 6,504,465 254.14
2025-04-18BUY27,414 234.560* 254.33
2025-04-17BUY27,414234.560235.120 235.064USD 6,444,044 254.51
2025-04-16BUY27,414230.500234.500 234.100USD 6,417,617 254.74
2025-04-15BUY27,414230.930242.150 241.028USD 6,607,541 254.96
2025-04-14BUY27,414240.010241.830 241.648USD 6,624,538 255.11
2025-04-11BUY27,414237.770240.000 239.777USD 6,573,247 255.28
2025-04-10BUY27,414226.280235.330 234.425USD 6,426,527 255.56
2025-04-09BUY27,414243.270245.560 245.331USD 6,725,504 255.68
2025-04-08BUY27,414224.320246.150 243.967USD 6,688,111 255.99
2025-04-07BUY27,414232.950241.830 240.942USD 6,605,184 256.23
2025-04-04BUY27,414235.740259.160 256.818USD 7,040,409 256.44
2025-04-02BUY27,414266.830267.290 267.244USD 7,326,227 256.33
2025-04-01BUY27,414255.760273.610 271.825USD 7,451,810 256.34
2025-03-31BUY27,414270.020271.850 271.667USD 7,447,479 256.19
2025-03-28BUY27,414268.460271.300 271.016USD 7,429,632 256.06
2025-03-27BUY27,414271.020276.570 276.015USD 7,566,675 255.90
2025-03-19SELL-51,509253.440255.350 255.159USD -13,142,985 254.80 Loss of -18,549 on sale
2025-03-10BUY130,432233.070244.330 243.204USD 31,721,584 255.90
2025-03-07BUY120,863244.520251.120 250.460USD 30,271,347 256.05
2025-02-19BUY51,509250.510254.010 253.660USD 13,065,773 257.76
2025-02-18BUY8,276250.000260.000 259.000USD 2,143,484 257.88
2025-02-14BUY8,276256.450264.870 264.028USD 2,185,096 257.92
2025-02-13BUY8,276264.890268.520 268.157USD 2,219,267 257.81
2025-02-12BUY8,276265.960268.200 267.976USD 2,217,769 257.68
2025-02-11BUY8,276268.990273.230 272.806USD 2,257,743 257.50
2025-02-10BUY8,276274.060276.230 276.013USD 2,284,284 257.22
2025-02-07BUY8,276276.190278.030 277.846USD 2,299,453 256.90
2025-02-06BUY8,276278.250279.240 279.141USD 2,310,171 256.53
2025-02-05BUY8,276276.310278.440 278.227USD 2,302,607 256.18
2025-02-04BUY8,276271.000277.980 277.282USD 2,294,786 255.92
2025-02-03BUY8,276274.550278.510 278.114USD 2,301,672 255.58
2025-01-31BUY8,276271.310279.340 278.537USD 2,305,172 255.29
2025-01-30BUY8,276277.160279.360 279.140USD 2,310,163 254.88
2025-01-29BUY8,276273.990279.700 279.129USD 2,310,072 254.51
2025-01-28BUY8,276279.190283.560 283.123USD 2,343,126 254.03
2025-01-27BUY8,276276.730287.220 286.171USD 2,368,351 253.57
2025-01-24BUY8,276278.760279.670 279.579USD 2,313,796 253.06
2025-01-23BUY8,276275.540277.220 277.052USD 2,292,882 252.59
2025-01-22SELL-8,276266.540269.140 268.880USD -2,225,251 257.00 Loss of -98,294 on sale
2025-01-21BUY8,276264.990265.020 265.017USD 2,193,281 256.83
2025-01-20BUY8,276 246.270* 257.06
2025-01-17BUY8,276246.270253.500 252.777USD 2,091,982 257.31
2025-01-15BUY8,276251.010255.300 254.871USD 2,109,312 257.65
2025-01-14BUY8,276240.510259.600 257.691USD 2,132,651 258.07
2025-01-13BUY8,276258.270261.860 261.501USD 2,164,182 258.07
2025-01-09BUY8,276 240.550* 259.06
2025-01-08BUY8,276240.550240.650 240.640USD 1,991,537 259.56
2025-01-02BUY8,276233.620239.990 239.353USD 1,980,885 260.28
2024-12-30BUY8,276236.010236.950 236.856USD 1,960,220 260.97
2024-12-10BUY8,276253.910257.990 257.582USD 2,131,749 261.18
2024-12-09BUY8,276255.890258.120 257.897USD 2,134,356 261.34
2024-12-06BUY8,276256.260257.810 257.655USD 2,132,353 261.50
2024-12-05BUY8,276251.810255.290 254.942USD 2,109,900 261.81
2024-12-04BUY8,276254.720256.680 256.484USD 2,122,662 262.05
2024-12-03BUY8,276251.840253.210 253.073USD 2,094,432 262.40
2024-12-02BUY8,276253.010255.290 255.062USD 2,110,893 262.73
2024-11-29BUY8,276253.070254.180 254.069USD 2,102,675 263.09
2024-11-28BUY8,276 253.740* 263.45
2024-11-27BUY8,276253.740256.020 255.792USD 2,116,935 263.84
2024-11-26BUY8,276253.350253.740 253.701USD 2,099,630 264.28
2024-11-21BUY8,276246.800250.710 250.319USD 2,071,640 266.57
2024-11-20BUY8,276248.790249.100 249.069USD 2,061,295 267.46
2024-11-19BUY8,276234.270235.940 235.773USD 1,951,257 269.21
2024-11-12BUY8,276268.950270.770 270.588USD 2,239,386 271.40
2024-11-11SELL-8,276279.820286.580 285.904USD -2,366,141 283.68 Loss of -18,401 on sale
2024-11-07SELL-8,276272.220275.070 274.785USD -2,274,121 284.89 Profit of 83,623 on sale
2024-10-31SELL-8,276266.590276.000 275.059USD -2,276,388 291.20 Profit of 133,620 on sale
2024-10-30SELL-8,276281.490287.870 287.232USD -2,377,132 292.02 Profit of 39,615 on sale
2024-10-29BUY11,081284.690287.020 286.787USD 3,177,887 293.07
2024-10-28BUY13,886286.910290.940 290.537USD 4,034,397 294.09
2024-10-24SELL-13,886293.690301.050 300.314USD -4,170,160 296.21 Loss of -57,057 on sale
2024-10-21SELL-13,886292.010295.390 295.052USD -4,097,092 295.93 Profit of 12,192 on sale
2024-10-18BUY13,886295.930298.940 298.639USD 4,146,901 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.